Collection of Czechoslovak Chemical Communications - digital archive 

Crossref Cited-by Linking

• Lamparska Katarzyna, Clark Jarrod, Babilonia Gail, Bedell Victoria, Yip Wesley, Smith Steven S.: 2′-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2′-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile sites. Nucleic Acids Research 2012, 40, 9788. <https://doi.org/10.1093/nar/gks706>
• Radnedge L, Pinney R J: Post-UV Survival and Mutagenesis in DNA Repair-proficient and -deficient Strains of Escherichia coli K-12 Grown in 5-Azacytidine to Inhibit DNA Cytosine Methylation: Evidence for Mutagenic Excision Repair. Journal of Pharmacy and Pharmacology 1993, 45, 192. <https://doi.org/10.1111/j.2042-7158.1993.tb05531.x>
• Pathak V K, Temin H M: 5-Azacytidine and RNA secondary structure increase the retrovirus mutation rate. J Virol 1992, 66, 3093. <https://doi.org/10.1128/jvi.66.5.3093-3100.1992>
• Parrow Vendela C., Aleström Peter, Gautvik Kaare M.: 5-Azacytidine-induced alterations in the GH12C1 cells: effects on cellular morphology, chromosome structure, DNA and protein synthesis. Journal of Cell Science 1989, 93, 533. <https://doi.org/10.1242/jcs.93.3.533>
• Lal Deepak, Som Subhendu, Friedman Stanley: Survival and mutagenic effects of 5-azacytidine in Escherichia coli. Mutation Research/DNA Repair Reports 1988, 193, 229. <https://doi.org/10.1016/0167-8817(88)90033-8>
• Cavaliere Antonio, Bufalari Andrea, Vitali Rino: 5-Azacytidine carcinogenesis in BALB/c mice. Cancer Letters 1987, 37, 51. <https://doi.org/10.1016/0304-3835(87)90145-5>
• Call Katherine M., Jensen Jorn C., Liber Howard L., Thilly William G.: Studies of mutagenicity and clastogenicity of 5-azacytidine in human lymphoblasts and Salmonella typhimurium. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1986, 160, 249. <https://doi.org/10.1016/0027-5107(86)90135-1>
• Podger D.M: Mutagenicity of 5-azacytidine in Salmonella typhimurium. Mutation Research Letters 1983, 121, 1. <https://doi.org/10.1016/0165-7992(83)90079-9>
• Marquardt Hans, Marquardt Hildegard: Induction of malignant transformation and mutagenesis in cell cultures by cancer chemotherapeutic agents. Cancer 1977, 40, 1930. <https://doi.org/10.1002/1097-0142(197710)40:4+<1930::AID-CNCR2820400826>3.0.CO;2-8>
• Fučík V., Zadražil S., Jurovčík M., Šormová Z.: Mechanism of resistance to 5-azacytidine inBacillus Subtilis. Folia Microbiol 1972, 17, 517. <https://doi.org/10.1007/BF02872738>
• Veselý J., Dvořák M., Čihák A., Šorm F.: Biochemical mechanisms of drug resistance — XII. Uridine kinases from mouse leukemic cells sensitive and resistant to 5‐azacytidine. Intl Journal of Cancer 1971, 8, 310. <https://doi.org/10.1002/ijc.2910080217>
• Fuǔík Vladimír, Michaelis Arnd, Rieger Rigomar: On the induction of segment extension and chromatid structural changes in Vicia faba chromosomes after treatment with 5-azacytidine and 5-azadeoxycytidine. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 1970, 9, 599. <https://doi.org/10.1016/0027-5107(70)90105-3>
• Halle S: 5-Azacytidine as a mutagen for arboviruses. J Virol 1968, 2, 1228. <https://doi.org/10.1128/jvi.2.10.1228-1229.1968>
• Veselý J., Čihák A., Šorm F.: Biochemical mechanisms of drug resistance IV. Development of resistance to 5‐azacytidine and simultaneous depression of pyrimidine metabolism in leukemic mice. Intl Journal of Cancer 1967, 2, 639. <https://doi.org/10.1002/ijc.2910020625>
• Doskočil J., Šorm F.: The action of 5-azacytidine on bacteria infected with bacteriophage T4. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1967, 145, 780. <https://doi.org/10.1016/0005-2787(67)90137-2>
• Zadražil Stanislav, Fučík Vladimír, Bartl Pavel, Šormová Zora, Šorm František: The structure of DNA from Escherichia coli cultured in the presence of 5-azacytidine. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis 1965, 108, 701. <https://doi.org/10.1016/0005-2787(65)90066-3>